[1]
Singh, A. et al. 2024. Pembrolizumab in combination with FOLFIRINOX for treatment of advanced pancreatic adenocarcinoma with MSI-H. European Journal of Case Reports in Internal Medicine. 11, 10 (Sep. 2024). DOI:https://doi.org/10.12890/2024_004767.